Dinesh Rakheja

33PUBLICATIONS
95CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)Data quality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 12, 2025
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors.

Matthew E Campbell, Sonja Stutzman, Sharon Primeaux

|Mar 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial.

Jay Jasti, Hua Zhong, Vandana Panwar

|Nov 06, 2024
KLF13 promotes SLE pathogenesis by modifying chromatin accessibility of key proinflammatory cytokine genes.

Andrew Wang, Anna-Marie Fairhurst, Kui Liu

|May 27, 2024
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors.

Rebecca R J Collins, Rebecca R Florke Gee, Maria Camila Hoyos Sanchez

|Nov 13, 2023
Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research.

Donghan M Yang, Qinbo Zhou, Lauren Furman-Cline

|Aug 08, 2023
Target-directed microRNA degradation regulates developmental microRNA expression and embryonic growth in mammals.

Benjamin T Jones, Jaeil Han, He Zhang

Pageof 6

Frequent Collaborators

3 joint publications

James F Amatruda

3 joint publications

James Brugarolas

3 joint publications

Payal Kapur

2 joint publications

Brian D Crompton